The Use of Melatonin for the Treatment of Insomnia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The pineal product melatonin is involved in the regulation of the sleep/wake cycle in humans. In blind individuals and in people travelling through time zones, melatonin rhythms are sometimes unsynchronized with the diel cycle, and nocturnal sleep may be disturbed. Low or distorted melatonin rhythms have repeatedly been reported in middle aged and elderly insomniacs. Melatonin administration effectively synchronized the sleep wake cycle in blind individuals and in subjects suffering from jet lag and advanced sleep onset in subjects suffering from delayed sleep phase syndrome. In elderly insomniacs, melatonin replacement therapy significantly decreased sleep latency, and/or increased sleep efficiency and decreased wake time after sleep onset. In addition, melatonin substitution facilitated benzodiazepine discontinuation in chronic users. These data show an association between melatonin rhythm disturbances and difficulties to promote or maintain sleep at night. Specific melatonin formulations may be useful to treat circadian-rhythm-related sleep disorders and age-related insomnia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*
REITER, R. J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-151 · Cited by 2,192
Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag
Suhner, A., Schlagenhauf, P., Johnson, R., Tschopp, A., & Steffen, R. (1998) · Chronobiology International · doi:10.3109/07420529808993201 · Cited by 147
Cited by
Melatonin—A pleiotropic, orchestrating regulator molecule
Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.004 · Cited by 843
Significance of Melatonin in Antioxidative Defense System: Reactions and Products
Tan, D.-X., Manchester, L. C., Reiter, R. J., Qi, W.-B., Karbownik, M., & Calvo, J. R. (2000) · Neurosignals · doi:10.1159/000014635 · Cited by 565
A Multicenter, Placebo-controlled Trial of Melatonin for Sleep Disturbance in Alzheimer's Disease
Singer, C., Tractenberg, R. E., Kaye, J., Schafer, K., Gamst, A., Grundman, M., Thomas, R., & Thal, L. J. (2003) · Sleep · doi:10.1093/sleep/26.7.893 · Cited by 407
Melatonin, human aging, and age-related diseases
Karasek, M. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.04.012 · Cited by 380
Melatonin: From Basic Research to Cancer Treatment Clinics
Vijayalaxmi, Thomas, C. R., Reiter, R. J., & Herman, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.004 · Cited by 361
Melatonin as a radioprotective agent: a review
Vijayalaxmi, Reiter, R. J., Tan, D.-X., Herman, T. S., & Thomas, C. R. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.02.006 · Cited by 303
LEMOINE, P., NIR, T., LAUDON, M., & ZISAPEL, N. (2007) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2007.00613.x · Cited by 261
Self-citationOlofsson, K., Alling, C., Lundberg, D., & Malmros, C. (2004) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.0001-5172.2004.00401.x · Cited by 257
Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction
Hardeland, R. (2012) · The Scientific World Journal · doi:10.1100/2012/640389 · Cited by 173
Metadata
- Authors
- Zisapel, N.
- Venue
- Neurosignals
- Publisher
- S. Karger AG
- Published
- 1999
- Volume
- 8
- Issue
- 1-2
- Pages
- 84-89
- ISSN
- 1424-862X (ISSN-L)
- 1424-8638
- OpenAlex
- W1967189029
- Cited by
- 43
- References
- 2
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.